Lieming Xu

815 total citations
24 papers, 651 citations indexed

About

Lieming Xu is a scholar working on Epidemiology, Hepatology and Pharmacology. According to data from OpenAlex, Lieming Xu has authored 24 papers receiving a total of 651 indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Epidemiology, 17 papers in Hepatology and 5 papers in Pharmacology. Recurrent topics in Lieming Xu's work include Liver Disease Diagnosis and Treatment (17 papers), Liver physiology and pathology (12 papers) and Liver Disease and Transplantation (5 papers). Lieming Xu is often cited by papers focused on Liver Disease Diagnosis and Treatment (17 papers), Liver physiology and pathology (12 papers) and Liver Disease and Transplantation (5 papers). Lieming Xu collaborates with scholars based in China, United States and Australia. Lieming Xu's co-authors include Ping Liu, Ping Jian, Yiyang Hu, Chenghai Liu, Yang Zhou, Na Jiang, Jing Zhang, Zhigang Lv, Cheng Liu and Mingyu Sun and has published in prestigious journals such as PLoS ONE, BioMed Research International and Oncotarget.

In The Last Decade

Lieming Xu

24 papers receiving 643 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Lieming Xu China 15 319 269 230 128 70 24 651
Beili Xu China 12 217 0.7× 183 0.7× 175 0.8× 122 1.0× 92 1.3× 13 644
Amro El‐Karef Egypt 16 174 0.5× 152 0.6× 236 1.0× 164 1.3× 53 0.8× 24 681
Fuxing Song China 7 176 0.6× 141 0.5× 120 0.5× 121 0.9× 39 0.6× 14 423
Chien‐Heng Shen Taiwan 19 213 0.7× 207 0.8× 342 1.5× 111 0.9× 45 0.6× 42 870
Yuehong Huang China 16 309 1.0× 224 0.8× 268 1.2× 61 0.5× 61 0.9× 34 739
Paloma Gallego Spain 12 314 1.0× 119 0.4× 272 1.2× 59 0.5× 40 0.6× 14 666
Keshu Xu China 17 377 1.2× 104 0.4× 303 1.3× 60 0.5× 52 0.7× 27 768
Sam Seok Cho South Korea 17 257 0.8× 148 0.6× 373 1.6× 68 0.5× 80 1.1× 27 794

Countries citing papers authored by Lieming Xu

Since Specialization
Citations

This map shows the geographic impact of Lieming Xu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lieming Xu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lieming Xu more than expected).

Fields of papers citing papers by Lieming Xu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Lieming Xu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lieming Xu. The network helps show where Lieming Xu may publish in the future.

Co-authorship network of co-authors of Lieming Xu

This figure shows the co-authorship network connecting the top 25 collaborators of Lieming Xu. A scholar is included among the top collaborators of Lieming Xu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Lieming Xu. Lieming Xu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Zhang, Jing, Ping Jian, Na Jiang, & Lieming Xu. (2022). Resveratrol inhibits hepatic stellate cell activation by regulating autophagy and apoptosis through the SIRT1 and JNK signaling pathways. Journal of Food Biochemistry. 46(12). e14463–e14463. 13 indexed citations
3.
4.
Xu, Lieming & Ping Liu. (2020). Guidelines for diagnosis and treatment of hepatic fibrosis with integrated traditional Chinese and Western medicine (2019 edition). Journal of Integrative Medicine. 18(3). 203–213. 32 indexed citations
5.
Zhou, Yang, Ping Jian, Tao Zhang, et al.. (2020). Fuzheng Huayu Capsule Attenuates Hepatic Fibrosis by Inhibiting Activation of Hepatic Stellate Cells. Evidence-based Complementary and Alternative Medicine. 2020(1). 3468791–3468791. 14 indexed citations
6.
Gui, Honglian, Changqing Zhao, Yan Wang, et al.. (2020). Histological Outcome of Fuzheng Huayu plus Entecavir Combination Therapy in Chronic Hepatitis B Patients with Significant Liver Fibrosis. Journal of Clinical and Translational Hepatology. 8(3). 1–8. 14 indexed citations
7.
8.
Yang, Fan, Qiaoling Yang, Xiaowen Tang, et al.. (2019). Sweroside ameliorated carbon tetrachloride (CCl4)-induced liver fibrosis through FXR-miR-29a signaling pathway. Journal of Natural Medicines. 74(1). 17–25. 26 indexed citations
9.
10.
Zhang, Hui, Xinxin Guo, Yi-Yu Lu, et al.. (2017). MiR-27a as a predictor for the activation of hepatic stellate cells and hepatitis B virus-induced liver cirrhosis. Oncotarget. 9(1). 1075–1090. 27 indexed citations
11.
Mu, Yongping, Wenwei Fu, Jiamei Chen, et al.. (2015). Yiguanjian decoction and its ingredients inhibit angiogenesis in carbon tetrachloride-induced cirrhosis mice. BMC Complementary and Alternative Medicine. 15(1). 342–342. 24 indexed citations
12.
13.
Weiskirchen, Ralf, Jörg Weimer, Steffen K. Meurer, et al.. (2013). Genetic Characteristics of the Human Hepatic Stellate Cell Line LX-2. PLoS ONE. 8(10). e75692–e75692. 56 indexed citations
14.
Sun, Mingyu, Fenghua Li, Cheng Liu, et al.. (2012). Ingredients of Huangqi decoction slow biliary fibrosis progression by inhibiting the activation of the transforming growth factor-beta signaling pathway. BMC Complementary and Alternative Medicine. 12(1). 33–33. 37 indexed citations
15.
16.
Sun, Mingyu, Hongyan Cao, Lin Sun, et al.. (2012). Antitumor Activities of Kushen: Literature Review. Evidence-based Complementary and Alternative Medicine. 2012. 1–11. 88 indexed citations
17.
Xu, Lieming. (2010). Observation of Treatment Effect and Hepatic Toxicity of Gardenia in Mouse with Acute Liver Injury. Liaoning Zhongyiyao Daxue xuebao. 2 indexed citations
18.
Liu, Chenghai, Yiyang Hu, Lieming Xu, Cheng Liu, & Ping Liu. (2009). Effect of Fuzheng Huayu formula and its actions against liver fibrosis. Chinese Medicine. 4(1). 12–12. 72 indexed citations
19.
Xu, Lieming. (2007). Effects of Salvianolic acid B on elevated portal pressure and hepatic endothelin-1 level in rat model of hepatocirrhosis. Chinese journal of integrated traditional and Western medicine. 1 indexed citations
20.
Zhao, Yidan, Lieming Xu, & John Chandler. (1995). Localization of Endothelin-Like Immunoreactivity and Endothelin Binding Sites in Rabbit Eyes. Journal of Cardiovascular Pharmacology. 26. S332–335. 23 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Beili Xu Breakdown of academic impact, for papers by Amro El‐Karef Breakdown of academic impact, for papers by Fuxing Song Breakdown of academic impact, for papers by Chien‐Heng Shen Breakdown of academic impact, for papers by Yuehong Huang Breakdown of academic impact, for papers by Paloma Gallego Breakdown of academic impact, for papers by Keshu Xu Breakdown of academic impact, for papers by Sam Seok Cho
Rankless by CCL
2026